Products:Cardiovascular >> Angiogenesis >> Growth Factors >> VEGF >> VEGF
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »This product is covered by the Abpromise guarantee. Our scientific support team are available to answer any questions or queries - fill out an inquiry form for ab1316 for help.
Alternatively, you can search the previous enquiries about this product to see if your query has already been answered.
|
|||||||||
|
|||||||||
Does this antibody detect or cross react with the most abundant VEGF isoforms in rats (120, 164 and 188) ? |
|||||||||
ANSWER: |
Thank you for contacting us. To our knowledge, the epitope for the VG-1 clone has not been mapped. While we cannot say for certain which isoforms will be recognized in rat, bands are observed at ˜27 and 31 kDa in rat dermal epithelium samples. I hope this helps, please let me know if you need any additional information or assistance. |
||||||||
|
|||||||||
Dear madam, |
|||||||||
ANSWER: |
Thank you for your answer. |
||||||||
|
|||||||||
Dear Madam/Sir, |
|||||||||
ANSWER: |
Thank you for your inquiry. |
||||||||
|
|||||||||
Hi, in response to your answer to my query below about detection of VEGF165b with anti-VEGF antibody ab1316, I was wondering if it would be possible for abcam to test the cross-reactivity. As of today, there are no known antibodies that have been tested that only react to VEGF165 but not its splice variant VEGF165b, and I feel this would be of enourmous benefit to the scientific community given the 'hot' status of VEGF165b and the importance of distinguishing between the two. Thank you, |
|||||||||
ANSWER: |
Thank you for your suggestion. I will will put it forward as a suggestion but I think ab1316 would not be the best candidate as having performed sequence analysis of the isoforms this antibody has been shown to recognise (121, 165 and 189) with that of 165b, it seems unlikely that it would be specific for either 165 of 165b. From the file I have attached, The sequence are as follows:
P15692-8 isoform 165b P15692-9 isoform 121 P15692-11 isoform 165 P15692-13 isoform 189 From this it can be seen that the 6 amino acid residues of the C-terminal which differentiates between the 165 and 165b isoform are not present at all in isoform 121. I would therefore suspect that the antibody is not binding in this region. I will however have a look through the rest of our catalogue to see if we have any other anti-VEGF antibodies which may be more likely to bind 165 specifically and put these forward for testing. I will let you know of my progress. If you have any further questions or suggestion we would be very pleased to hear them. |
||||||||
|
|||||||||
Phone call enquiring as to whether ab1316 is able to recognise isoform 165b of VEGF |
|||||||||
ANSWER: |
Thank you for contacting us in regards to Anti-VEGF antibody [VG-1] (ab1316). I’m afraid we currently have no information on whether this antibody would recognise the VEGF isoform 165b. The full length recombinant protein is used as the immunogen and in depth epitope mapping has as yet not been performed. However, as the only difference between the isoforms 165 and 165b is the final 6 C-terminal amino acids I think there is a good chance the antibody recognises a different region. I cannot guarantee it though. We have two antibodies in our catalogue where the VEGF 165b is specifically recognised: ab14994 is a mouse monoclonal which has been used to detect human and rat protein. ab90719 is a rabbit polyclonal which has been used to detect human VEGF 165b. Depending on the applications you intend to use one of these antibodies may be suitable for you. I hope this information has been of help. If you would like any further information please do let me know. |
||||||||
|
|||||||||
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
ab1316 at 10µg/ml staining human retinal pigment epithelial cells. The antibody was incubated with the cells for 6 hours and then detected with Alexa-Fluor ® 568 goat anti-mouse (IgG) antibody.
This image is courtesy of an Abreview submitted on 16 November 2005.
All lanes : Anti-VEGF antibody [VG-1] (ab1316) at 10 µg/ml
Lane 1 : Jurkat (Human T cell lymphoblast-like cell line) Whole Cell Lysate
Lane 2 : A431 (Human epithelial carcinoma cell line) Whole Cell Lysate
Lane 3 : HepG2 (Human hepatocellular liver carcinoma cell line) Whole Cell Lysate
Lysates/proteins at 20 µg per lane.
Secondary
Goat polyclonal to Mouse IgG - H&L - Pre-Adsorbed (HRP) (ab65485) at 1/3000 dilution
Predicted band size : 24, 45 kDa
Observed band size : 43 kDa (why is the actual band size different from the predicted?)
Additional bands at : 125 kDa,52 kDa. We are unsure as to the identity of these extra bands.
ICC/IF image of ab1316 stained HeLa cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab1316, 10µg/ml) overnight at +4ºC. The secondary antibody (green) was Alexa Fluor® 488 goat anti-mouse IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM. This antibody also gave a positive result in 100% methanol fixed (5 min) Hek293, HepG2 and MCF7 cells at 10µg/ml, and in 4% PFA fixed (10 min) HeLa, Hek293, HepG2 and MCF7 cells at 10µg/ml.
ab1316 staining VEGF in Human MDA-MD-231 cells injected into the mouse mammary fat pad by Immunohistochemistry (IHC-P - formaldehyde-fixed, paraffin-embedded sections). Tissue was fixed with paraformaldehyde, permeabilized with Tween in PBS and blocked with 1.5% serum for 1 hour at 25ºC; antigen retrieval was by heat mediation in citrate buffer. Tissue samples were incubated with primary antibody (1/200 in PBST +1% BSA) for 16 hours at 4ºC. A biotin-conjugated Goat anti-mouse IgG polyclonal (1/200) was used as the secondary antibody. Tissue was counterstained with Hematoxylin (1/10) for 30 seconds at room temperature and rinsed with water.
This image is courtesy of an anonymous Abreview
IHC image of ab1316 staining in human heart formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab1316, 5µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
26
Call 01223 696 000 or contact us